Alucent Biomedical, Inc.

Alucent Biomedical, Inc. is a medical technology company based in Salt Lake City, Utah. The company specializes in the development of the Alucent NVS Vessel Restoration System™, which utilizes proprietary Natural Vascular Scaffolding™ (NVS) technology. This innovative system is designed to stent and maintain vessel patency without the need for permanent implants, offering a new approach to interventional vascular therapy. The core product, the AlucentNVS, is a light-activated, drug-coated balloon catheter that combines an intravascular device with a photochemical process. This process links structural proteins in the blood vessel wall, promoting sustained vessel lumen patency and preserving the natural function of the vascular wall. Alucent Biomedical primarily targets patients with peripheral arterial disease (PAD) and is also exploring applications for arteriovenous fistula maturation in hemodialysis patients. Founded in 2017, Alucent has received significant investment for technology development and is currently conducting clinical trials to evaluate the safety and efficacy of its system. The company aims to address significant unmet medical needs in vascular health through its innovative solutions.

• Employees 7
• Founded 2017
• Total Funding $34999999